Lung cancer stigma stems from its association with smoking, affecting patients' emotional well-being and support systems.

The FDA approved Keytruda for NSCLC based on several clinical trials. Keytruda was studied in people whose NSCLC had spread to other parts of the body (metastatic) and who had received no prior ...

Please provide your email address to receive an email when new articles are posted on . Factors related to smoking (nicotine dependency, self-efficacy for quitting) impacted uptake of cessation ...

In a recent review published in Nature Reviews Clinical Oncology, scientists discussed the development of lung cancer in individuals who have never smoked (LCINS). This review particularly focussed on ...

At a Patient Reception on 6th December 2025, 20 leaders from 17 patient advocacy groups from across Asia Pacific, Europe and the United States shared their support for the need to strengthen shared ...